3D modelling

Scientist working in the lab
#3D cell culture #3D modelling #ADME / Tox #Drug toxicity #Pharmokinetics #Webinar

Webinar: Building advanced cell models for toxicity testing

Join DDW and Lonza for this free event ‘Building advanced cell models for toxicity testing’. The event will take place on 19 September at 3pm GMT / 4pm CET / 10am EST / 7am PST. Life sciences researchers need a host… Read More

Webinar date:
Supported by Lonza
#News

Scientist working in the lab
#3D cell culture #3D modelling #ADME / Tox #Drug toxicity #Pharmokinetics

Building advanced cell models for toxicity testing

Life sciences researchers need a host of tools to develop and test critical disease-treating drugs and therapies, from basic research to final product release. Primary cells, media, and reagents are all important for supporting preclinical and clinical pharmaceutical workflows for drug discovery and absorption, distribution, metabolism, excretion, and toxicity (ADMET)… Read More

Webinar date:
Supported by Lonza
#Webinars

#3D modelling #Artificial intelligence (AI) #BioPharmics #Computational chemistry #Mergers and acquisitions #Molecular Biology #Optibrium

Optibrium acquires BioPharmics

AI drug discovery company Optibrium has acquired 3D drug design specialist BioPharmics. BioPharmics’ CEO, Dr Ajay Jain, and Director of Applied Science, Dr Ann Cleves, will join the Optibrium team, respectively focusing on R&D and Application Science in the newly-created BioPharmics Division. BioPharmics has… Read More

#Business & Investment #News

#3D modelling #Biochemistry #CRISPR #DNA #Drug discovery #Gene editing #Genomics #Mass spectrometry / NMR #Screening

Podcast: Mass spectrometry and CRISPR

This is the latest episode of the free DDW podcast, “Mass spectrometry and CRISPR are pillars of drug discovery”. It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “How ASMS offers more than seeing what sticks” and “… Read More

#News

#3D modelling #Cell culture #Organoids

3D Model Systems ebook out now – Spheroids, Organoids, and Tissue Models

Culturing cells in 3D is simply a more realistic way to model how cells move and function in vitro. Spheroids, organoids, and more complex 3D systems have been invaluable to research, drug discovery, and personalised medicine. This e-book, sponsored by Corning, offers a practical guide for demystifying spheroids and organoids… Read More

#DDW eBooks

#3D modelling #Automation / robotics

Biodispensing platform launched for 3D cell culture automation 

CELLINK, A BICO company, has launched BIO CELLX, a novel system that automates 3D cell culture workflows by leveraging pre-validated protocols.   The platform  The BIO CELLX builds upon CELLINK’s bioprinting portfolio which utilises technologies. By introducing the concept of pre-validated protocols, the platform provides… Read More

#News

#3D modelling #Chemistry #Technology

New software empowers researchers to rapidly create reports 

PerkinElmer Informatics has announced version 21 of its ChemDraw software, which provides researchers with the ability to import, animate and share 3D chemical structures natively in the Microsoft PowerPoint application.   Impact  The key enhancement helps chemists create more intelligent research reports quickly and easily, improving… Read More

#News

CRISPR gene editing
#3D modelling #CRISPR #DNA #Drug discovery #Gene editing #Genomics #Screening

CRISPR screening in the third dimension 

Listen to this article on the DDW Podcast: Rosie Bryan & Carlos le Sage, Horizon Discovery, explain how CRISPR-Cas9 technology has become a gold standard for functional genomics.  While efforts in the cancer genomics field have uncovered the mutational landscapes in tumours covering many types of cancer, the… Read More

#Editor's Choice #Exclusive Content #News

#3D modelling #DNA #Drug development #Library screening #Screening

NovAliX enters partnership to design and screen new DNA-encoded libraries 

NovAliX, a CRO specialising in drug research and development, has partnered with Sanofi for the development of new DNA-Encoded Libraries (DELs), allowing the partners to design both general and focused chemical libraries, and carry out screening activities to identify new and useful chemical structures.  Why is this useful? … Read More

#News

#3D modelling #Cell painting #Lab automation #Software

Cell image software to streamline drug discovery decision-making 

PerkinElmer has launched Signals Image Artist software, an image analysis and management platform for drug discovery research. The new offering is designed to help scientists accurately process and analyse their high-content screening (HCS) and cellular imaging data in a matter of hours, versus days or weeks, so they can make… Read More

#News

#3D modelling #Liver disease

Ready-to-go spheroids + media for drug discovery

More physiologically and pathologically relevant preclinical human liver models are needed for drug liver liability assessment and liver disease modeling. While Drug-Induced Liver Injury (DILI) remains a major safety concern, several recent high-profile NAFLD/NASH clinical trial failures further highlight this critically unmet need. With the advances in 3D culture, we… Read More

#Intelligence #Resources

Human liver
#3D modelling #Liver disease

Insight on ready-to-go spheroids and media for drug discovery 

More physiologically and pathologically relevant preclinical human liver models are needed for drug liver liability assessment and liver disease modeling. This app note offers insight and media for drug discovery.  While Drug-Induced Liver Injury (DILI) remains a major safety concern, several recent high-profile NAFLD/NASH clinical trial failures further… Read More

#News

#3D modelling #Cancer research #Cell therapy #Tumour biology

Prostate cancer therapy may fuel spread of bone tumours 

Anti-androgen therapy is commonly used to treat patients with advanced prostate cancer which has spread to the bones, however, the treatment may be fuelling bone cancer spread.  Dr Nathalie Bock from QUT Centre for Biomedical Technologies focused her research on bone metastases from breast and prostate cancers. Read More

#Cancer Research #News

#3D modelling #Clinical trials #Drug development #Drug discovery

Lonza and CN Bio hepatocyte distribution agreement

Lonza and CN Bio have entered into a distribution agreement where Lonza will supply a selection of hepatic cells to be prequalified by CN Bio for use in its PhysioMimix Single-and Multi-Organ MPS. The aim is to change the way human-relevant pre-clinical data is generated. With prequalified cells, customers can… Read More

#News

#3D modelling #Immunology #In vitro #Microbiome #Research

King’s College London uses CN Bio to investigate chronic liver disease

King’s College London is using CNBio’s PhysioMimix Multi-Organ MPS. Following a research collaboration, King’s College London selected the system to create a human-relevant liver-intestinal model for characterising and manipulating host-microbial interactions, to support improved outcomes in cirrhosis. Launched in March 20211, the product combines CN Bio’s in vitro 3D liver… Read More

#News

#3D modelling #Assay development optimisation & technology #Corning Life Sciences #Drug efficacy #Life sciences

All-in-one solution for the development of 3D liver models

The HepGo Assay-ready 3D Liver Spheroid Kit leverages Corning Life Science’s 3D cell culture technology in liver biology and ADME/Tox. Corning has developed an all-in-one solution for the development of 3D liver models that has been designed to better recapitulate in vivo behaviour. The kit is said to deliver a… Read More

#News